SCHEMBL20470744

SCHEMBL20470744

Cc1cnc(C#CS(C)(C)C)cn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15478295 0.76 — —
SCHEMBL20470939 0.72 KCNH2 (0.37) —
SCHEMBL18478408 0.71 CYP1A2 (0.41) —
SCHEMBL8313377 0.71 CYP1A2 (0.34) —
SCHEMBL8313298 0.69 KMT2A (0.32) —
SCHEMBL5684095 0.69 — —
SCHEMBL1923494 0.69 — —
SCHEMBL31742514 0.69 — —
SCHEMBL21189786 0.68 GRM5 (0.50) —
SCHEMBL82304 0.68 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10246429-B2 Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use AMGEN INC. (US) 2019-04-02 — — US disclosed
US-20180222876-A1 VINYL FLUORIDE CYCLOPROPYL FUSED THIAZIN-2-AMINE COMPOUNDS AS BETA-SECRETASE INHIBITORS AND METHODS OF USE AMGEN INC. (US) 2018-08-09 — — US disclosed
Send feedback